Physician profile
Ashish Nanda
NPI 1598980518
$65,787.27
in general payments reported to CMS, 2019-2025
14 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,146 · 2020: $7,453 · 2021: $2,401 · 2022: $6,905 · 2023: $13K · 2024: $33K · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Food and Beverage: $4,607 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Travel and Lodging: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,376.42 |
| Food and Beverage | $4,606.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Travel and Lodging | $499.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $50,518.32 | 2019-2025 | Penumbra System, Penumbra Coil 400, Red 72 |
| Medical Device Business Services, INC. | $11,383.85 | 2024 | Embotrap, Trufill, Cerepak Uniform |
| Depuy Synthes Sales INC. | $1,314.85 | 2020-2024 | Trufill |
| Stryker Corporation | $1,304.59 | 2021-2025 | Target, Axs Vecta 71, Trevo |
| Medtronic, INC. | $338.73 | 2021-2025 | Pipeline |
| Imperative Care, INC | $225.76 | 2021-2022 | |
| Access Pro Medical, LLC | $190.24 | 2025 | Matriderm |
| Scientia Vascular | $180.81 | 2024 | Socrates 38, Colossus |
| Acera Surgical, INC. | $148.38 | 2024 | Restrata Wound Matrix |
| Medtronic USA, INC. | $83.08 | 2019 | |
| Microvention, INC. | $33.04 | 2019-2020 | |
| Boston Scientific Corporation | $32.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.01 | 2022 | |
| Medtronic Vascular, INC. | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.